November 15, 2019 Issue

Industry News

  • Cassiopea announces FDA acceptance of its new drug application for clascoterone cream 1%, the first new mechanism of action for acne in nearly 40 years. 

New Medical Research

  • Acne fulminans and cutibacterium acnes phylotypes. 
  • Evaluation of the safety and efficacy of a picosecond alexandrite laser with DLA for acne scars in Chinese patients. 
  • Treatment of erythematotelangiectatic rosacea with pulsed-dye laser and oxymetazoline 1.0% cream: A retrospective study. 
  • Impact of nanostructured lipid carriers on dapsone delivery to the skin; In vitro and in vivo studies. 
  • Use of a monofilament debridement pad in the treatment of acne vulgaris. 
  • Establishment of an anti-acne vulgaris evaluation method based on TLR2 and TLR4-mediated interleukin-8 production. 
  • Prevalence and psychological impact of acne vulgaris in female undergraduate medical students of Rawalpindi and Islamabad, Pakistan. 

Clinical Reviews

  • Serum IL-36α, IL-36β, and IL-36γ levels in patients with hidradenitis suppurativa: Association with disease characteristics, smoking, obesity, and metabolic syndrome. 
  • Acne from the young patient's perspective. 
  • Trifarotene: First approval. 
  • The skin and gut microbiome and its role in common dermatologic conditions. 
  • Acne vulgaris: A patient and physician's experience. 
  • Young people's perceptions of acne and acne treatments: Secondary analysis of qualitative interview data. 
  • Demographic and clinical features of hidradenitis suppurativa in Turkey. 
  • Prevalence and impact of dietary avoidance among individuals with hidradenitis suppurativa. 
  • Blue-light therapy for acne vulgaris: A systematic review and meta-analysis. 
  • Skin changes in the obese patient. 
  • Incorporation of benzoyl peroxide nanocrystals into adapalene-loaded solid lipid microparticles: Part II - solid-in-oil dispersion of nanoparticulate benzoyl peroxide.
  • Sarecycline hydrochloride for the treatment of acne vulgaris. 
  • Treatment of Demodex-associated inflammatory skin conditions: A systematic review. 
  • Association of rosacea with inflammatory bowel disease: A MOOSE-compliant meta-analysis. 
  • Skin disease related to metabolic syndrome in women.

Click Here to Download the AARS Hot Topics Newsletter